Ftse Mib
34.676,17
1,15%
DAX
19.254,97
1,03%
S&P 500
5.728,80
0,41%
NASDAQ
18.239,92
0,80%
Bitcoin
69.654,20
0,25%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Metagenomi Inc (MGX) Metagenomi Inc (MGX) Notizie

Metagenomi Inc

MGX
2,1485
0,1785 (9,06%)
02 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/10/202410:45PRNUSMetagenomi, Inc. Sued for Securities Law Violations -..
28/10/202410:45PRNUSShareholders that lost money on Metagenomi, Inc.(MGX) Urged..
24/10/202414:04GLOBEMetagenomi Presents Novel, Highly Specific and Efficient..
17/10/202411:45PRNUSMetagenomi, Inc. Sued for Securities Law Violations -..
15/10/202402:58GLOBEMetagenomi Presents Compact SMART Editing Platform at AIChE..
14/10/202411:45PRNUSShareholders that lost money on Metagenomi, Inc.(MGX) should..
10/10/202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
07/10/202411:45PRNUSShareholders of Metagenomi, Inc. Should Contact The Gross..
30/9/202411:45PRNUSInvestors who lost money on Metagenomi, Inc.(MGX) should..
20/9/202401:15GLOBEMetagenomi to Present at Chardan's 8th Annual Genetic..
06/9/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:09EDGAR2Form 8-K - Current report
03/9/202422:05GLOBEMetagenomi Announces Preclinical Data for Lead Hemophilia A..
30/8/202401:32GLOBEMetagenomi Presents AI-Enabled Advancements of SMART Editing..
29/8/202400:10GLOBEMetagenomi to Participate in Upcoming Investor Conferences
14/8/202414:18EDGAR2Form 8-K - Current report
14/8/202414:05GLOBEMetagenomi Reports Business Updates and Second Quarter 2024..
14/8/202414:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/5/202422:00GLOBEMetagenomi to Present at the 2024 Jefferies Global..
14/5/202422:08EDGAR2Form 8-K - Current report
14/5/202422:05GLOBEMetagenomi Presents Data at Scientific Conferences and First..
14/5/202422:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/5/202400:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/5/202422:00GLOBEMetagenomi to regain full development rights to its..
08/4/202414:00GLOBEMetagenomi to Present at Upcoming Scientific Meetings
27/3/202414:16GLOBEMetagenomi Reports Business Updates and Full Year 2023..
29/2/202422:30GLOBEMetagenomi to Participate in the 44th Annual Cowen..
13/2/202422:35GLOBEMetagenomi Announces Closing of Initial Public Offering
09/2/202404:16GLOBEMetagenomi Announces Pricing of Initial Public Offering
Apertura: 1,97 Min: 1,97 Max: 2,16
Chiusura: 1,97

La tua Cronologia

NASDAQ
MGX
Metagenomi
BIT
F35758
Vontobel Financial Produ...
BIT
3GFM
Graniteshares 3x Long Ga...
BIT
ISAD
AMUNDI MSCI USA ESG LEAD...
AMEX
CATX
Perspective Therapeutics
NYSE
EVF
Eaton Vance Senior Income
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network